lifestyle.travelshq.com

Author: Wellgistics Health, Inc.

Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026

May 15, 2026
Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program

May 14, 2026
Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services

May 13, 2026
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

April 14, 2026
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

March 23, 2026
Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

March 19, 2026
Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction

March 13, 2026
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities

March 11, 2026
Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)

March 9, 2026
Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate

March 5, 2026